Raaijmakers, P.F.J.

prostate cancer prostate cancer biopsy screening study value range level round detection erspc european randomized study rotterdam antigen patient tumour j urol 3.0 ng /ml 4.0 ng /ml gunma volume result prostate carcinoma 3.0 psa levels prostate biopsy 4.0 carcinoma rectal examination table complication psa values group increase 2.0 randomized number psa ranges sextant 4 years european psa range cohort characteristic transrectal dutch biopsy indication progression difference baseline participant psa level risk factors interval urology psa value prostate-specific population prostate volume japanese sextant biopsy rectal serum chapter indication finding examination section unfavourable tumour characteristics psa increases procedure factor 3.9 sensitivity probability diagnosis prostatic prostate cancer screening method